Nurix Therapeutics
NRIX
Nurix Therapeutics (NRIX) news
Recent news
Nurix Therapeutics - eligible for about $453 mln in future STAT6 milestones and potential royalties
AInvest Wire · Aug 4, 2026Nurix Therapeutics - has received about $139 mln under 2019 Sanofi collaboration
AInvest Wire · Aug 4, 2026Nurix announces $10M milestone payment associated with
AInvest Wire · Aug 4, 2026Nurix Therapeutics Inc: Morgan Stanley raises target price to $38 from $36
AInvest Wire · Jul 28, 2026Nurix Therapeutics Inc: UBS raises target price to $31 from $23
UBS has raised its price target for Nurix Therapeutics (NASDAQ:NRIX) to $31 from $23, while maintaining a Buy rating, according to recent analyst updates. This adjustment follows Nurix’s second-quarter 2025 financial results and corporate updates, which highlighted progress in its lead program,…
AInvest Wire · Jul 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.